Shu‐Qiang Weng
- Topics
- MicroRNA in disease regulation (6 papers)Cancer-related molecular mechanisms research (6 papers)Ferroptosis and cancer prognosis (5 papers)
In The Last Decade
Shu‐Qiang Weng
35 papers receiving 939 citations
Peers
Comparison fields: 5 of 89
- Molecular Biology 631
- Cancer Research 346
- Oncology 138
- Epidemiology 104
- Pulmonary and Respiratory Medicine 97
Countries citing papers authored by Shu‐Qiang Weng
This map shows the geographic impact of Shu‐Qiang Weng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu‐Qiang Weng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu‐Qiang Weng more than expected).
Fields of papers citing papers by Shu‐Qiang Weng
This network shows the impact of papers produced by Shu‐Qiang Weng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu‐Qiang Weng. The network helps show where Shu‐Qiang Weng may publish in the future.
Co-authorship network of co-authors of Shu‐Qiang Weng
This figure shows the co-authorship network connecting the top 25 collaborators of Shu‐Qiang Weng. A scholar is included among the top collaborators of Shu‐Qiang Weng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shu‐Qiang Weng. Shu‐Qiang Weng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 7 | |
| 4 | 10 | |
| 5 | 3 | |
| 6 | 9 | |
| 7 | 20 | |
| 8 | 9 | |
| 9 | 36 | |
| 10 | 41 | |
| 11 | 11 | |
| 12 | 3 | |
| 13 | 6 | |
| 14 | 42 | |
| 15 | 31 | |
| 16 | 192 | |
| 17 | 23 | |
| 18 | 19 | |
| 19 | 33 | |
| 20 | 11 |
About Shu‐Qiang Weng
Shu‐Qiang Weng is a scholar working on Cancer Research, Hepatology and Oncology, having authored 36 papers that have together received 949 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (6 papers), Cancer-related molecular mechanisms research (6 papers) and Ferroptosis and cancer prognosis (5 papers). The work is most often cited by research in Cancer Research (346 citations), Molecular Biology (631 citations) and Hepatology (61 citations). Shu‐Qiang Weng has collaborated with scholars based in China, Canada and Germany. Frequent co-authors include Ling Dong, Xizhong Shen, Taotao Liu, Ji‐Min Zhu, Danying Zhang, Xiang‐Nan Yu, Lin Zhu, Guangqi Song, Hong Zhu and Yu Hu. Their work appears in journals such as PLoS ONE, Oncogene and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.